about
Tapentadol enantiomers: Synthesis, physico-chemical characterization and cyclodextrin interactions.Analytical and biological characterization of halogenated gemfibrozil produced through chlorination of wastewater.NMR methods to monitor the enzymatic depolymerization of heparin.Heparin characterization: challenges and solutions.Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.Comparison of GC-MS and NMR for metabolite profiling of rice subjected to submergence stress.Characterization and identification of isoflavonoid glycosides in the root of Spiny restharrow (Ononis spinosa L.) by HPLC-QTOF-MS, HPLC-MS/MS and NMR.Separation of vinca alkaloid enantiomers by capillary electrophoresis applying cyclodextrin derivatives and characterization of cyclodextrin complexes by nuclear magnetic resonance spectroscopy.Synthesis and characterization of long-chain tartaric acid diamides as novel ceramide-like compounds.Separation and characterization of modified pregabalins in terms of cyclodextrin complexation, using capillary electrophoresis and nuclear magnetic resonance.Theoretical problems associated with the use of acetic anhydride as a co-solvent for the non-aqueous titration of hydrohalides of organic bases and quaternary ammonium salts.Clickable fluorophores for biological labeling--with or without copper.Characterisation of diarylheptanoid- and flavonoid-type phenolics in Corylus avellana L. leaves and bark by HPLC/DAD-ESI/MS.Acid-base profiling of imatinib (gleevec) and its fragments.A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization.Characterization of aspartame-cyclodextrin complexation.Triprotic acid-base microequilibria and pharmacokinetic sequelae of cetirizine.Glycosaminoglycans: oligosaccharide analysis by liquid chromatography, capillary electrophoresis, and specific labeling.Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.Getting to know the nitrogen next door: HNMBC measurements of amino sugars.Understanding the effect of the counterion on the reverse-phase ion-pair high-performance liquid chromatography (RPIP-HPLC) resolution of heparin-related saccharide anomers.Resolution of carboxylate protonation microequilibria of NTA, EDTA and related complexones.Differential metabolic regulation governed by the rice SUB1A gene during submergence stress and identification of alanylglycine by 1H NMR spectroscopy.Molecular interactions in imatinib-DPPC liposomes.Characterization of a single-isomer carboxymethyl-beta-cyclodextrin in chiral capillary electrophoresis.Qualitative and quantitative analysis of PDE-5 inhibitors in counterfeit medicines and dietary supplements by HPLC-UV using sildenafil as a sole reference.Chiral recognition of imperanene enantiomers by various cyclodextrins: a capillary electrophoresis and NMR spectroscopy study.A non-fluorinated monobenzocyclooctyne for rapid copper-free click reactions.Single-isomer carboxymethyl-γ-cyclodextrin as chiral resolving agent for capillary electrophoresis.Qualitative and quantitative analysis of N-acetyllactosamine and lacto-N-biose, the two major building blocks of human milk oligosaccharides in human milk samples by high-performance liquid chromatography-tandem mass spectrometry using a porous grapChiral separation of asenapine enantiomers by capillary electrophoresis and characterization of cyclodextrin complexes by NMR spectroscopy, mass spectrometry and molecular modeling.Sulfate esters of morphine derivatives: Synthesis and characterizationPhytochemical analysis of Ononis arvensis L. by liquid chromatography coupled with mass spectrometryThe efficient structure elucidation of minor components in heparin digests using microcoil NMRHomo- and hetero-difunctionalized β-cyclodextrins: Short direct synthesis in gram scale and analysis of regiochemistryCyclodextrin/imatinib complexation: binding mode and charge dependent stabilitiesGels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulationsCombined use of liquid chromatography with mass spectrometry and nuclear magnetic resonance for the identification of degradation compounds in an erythromycin formulationChiral recognition of dapoxetine enantiomers with methylated-gamma-cyclodextrin: a validated capillary electrophoresis methodCharacterization of phenolic compounds and antinociceptive activity of Sempervivum tectorum L. leaf juice
P50
Q30691626-195BC466-DDF6-4508-A4A8-98B601C21874Q34228745-E22BF030-59BC-4D44-BC48-56AE2FF21E95Q34463103-422DD773-F4F9-4E97-B313-E5357187F483Q37862245-3B19A2EF-4BF9-4E10-8695-BE096914FF03Q38325237-61BB5216-2090-49F4-B9D4-1303C824C1D0Q38893109-A4121809-C598-4C17-85FB-BD862A48980AQ39999266-F318AF59-1D2A-4969-A35E-30A1B459FD1DQ42932057-78402D0D-9D17-4A8B-B849-736F6EE1FBE7Q43119491-85590153-F234-4315-9D84-2A43E91ABA5FQ43242209-0A7C008A-1612-48CA-9359-055724A7BC42Q43291553-F0E2F7B1-8B62-46F3-9DE6-1072288C7970Q43292703-47B4E78A-F051-46EE-8EA5-7816E7C20EA0Q44072137-54B5C281-B80F-44A0-8B14-FD9F65EBDAF1Q45212838-5D5AF158-9625-4DF5-B58B-FB84DCDA7A5DQ45288080-75A06CCD-13A8-4FC1-A031-887BE7BCA10DQ45935338-3F326550-9737-48EF-8672-5CE4E656462BQ45985476-1B11ABEC-627C-4A22-992B-0216015EADD1Q46044184-E3D805C3-8AB7-489F-974E-982769BC18D4Q46403920-10308B65-7695-4AA2-9530-958F8ED49CC7Q46422890-445C5C8B-BEF9-427C-902D-332492EBD6F1Q46470057-E70C7797-8974-4EAE-AE69-2211D1BBC19AQ46678353-5F8CCD93-01CC-47DD-B188-F184732DDBCAQ46698690-B9F6C403-AE99-425A-BA5C-178098F77B10Q46805546-A41A2F3A-380B-42BE-9B44-2BA18BAB3FBEQ48319597-8DB933A4-7DFD-4697-9321-0EB2D3B4B2CBQ48849712-AE7A3342-E1D4-4198-B230-50596EC87C52Q51360634-4EC72060-F0E6-409D-BC58-51A4270CB665Q51762752-0EF5A9D2-70CD-49CF-985F-93BB663A4973Q52988492-27917FC1-2410-41A6-8E60-BE6F14E8E903Q53479126-967FF7B1-FE75-4C3F-8EF9-C7360B2A50D9Q53500693-1FC9CDA0-E2D2-4E20-9425-F5CB38884E97Q57566193-AEB1A9A6-2052-4C63-83FC-041FAF43E996Q58583555-A4440FB8-FF69-4867-8CEC-93A122340454Q61165464-27615714-3967-44CA-9D52-150A279EE1A1Q64078430-D18A84D6-9C47-4D8B-8503-3257207DF2FFQ79404103-7129A71C-F901-4C30-9561-B3B81856070CQ80404813-0A695FF9-6DF6-4C9D-A31A-1E9CDD22959DQ82044853-2ACC0162-14D8-499F-B727-23CF46A19914Q83332806-214CD060-9E87-4635-B31B-84BE026197D8Q84564445-226773F6-900A-44B3-9DBE-EF2DC1E3FFEF
P50
description
Chemist
@en
wetenschapper
@nl
հետազոտող
@hy
name
Szabolcs Béni
@ast
Szabolcs Béni
@en
Szabolcs Béni
@es
Szabolcs Béni
@nl
Szabolcs Béni
@sl
type
label
Szabolcs Béni
@ast
Szabolcs Béni
@en
Szabolcs Béni
@es
Szabolcs Béni
@nl
Szabolcs Béni
@sl
prefLabel
Szabolcs Béni
@ast
Szabolcs Béni
@en
Szabolcs Béni
@es
Szabolcs Béni
@nl
Szabolcs Béni
@sl
P1053
B-4884-2009
P106
P1153
10144017000
P1960
-r_PNPIAAAAJ
P21
P31
P3829
P496
0000-0001-7056-6825